Vilin Bio Med Balance Sheet Health
Financial Health criteria checks 4/6
Vilin Bio Med has a total shareholder equity of ₹234.5M and total debt of ₹55.2M, which brings its debt-to-equity ratio to 23.6%. Its total assets and total liabilities are ₹309.4M and ₹75.0M respectively. Vilin Bio Med's EBIT is ₹28.3M making its interest coverage ratio 4. It has cash and short-term investments of ₹65.3M.
Key information
23.6%
Debt to equity ratio
₹55.24m
Debt
Interest coverage ratio | 4x |
Cash | ₹65.32m |
Equity | ₹234.47m |
Total liabilities | ₹74.98m |
Total assets | ₹309.44m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VILINBIO's short term assets (₹266.2M) exceed its short term liabilities (₹71.7M).
Long Term Liabilities: VILINBIO's short term assets (₹266.2M) exceed its long term liabilities (₹3.3M).
Debt to Equity History and Analysis
Debt Level: VILINBIO has more cash than its total debt.
Reducing Debt: Insufficient data to determine if VILINBIO's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: VILINBIO's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: VILINBIO's interest payments on its debt are well covered by EBIT (4x coverage).